Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice.
Document Type
Article
Publication Date
8-1-2012
Institution/Department
Maine Behavioral Health
Journal Title
Journal of autism and developmental disorders
MeSH Headings
Child, Child Development Disorders, Pervasive, Evidence-Based Practice, Humans, Psychotropic Drugs, Treatment Outcome
Abstract
This paper presents a systematic review, rating and synthesis of the empirical evidence for the use of psychotropic medications in children with autism spectrum disorders (ASD). Thirty-three randomized controlled trials (RCTs) published in peer-reviewed journals qualified for inclusion and were coded and analyzed using a systematic evaluative method specific to autism research (Reichow et al. in Journal of Autism and Developmental Disorders 38:1311-1319, 2008). Results are presented by agent and primary target symptom(s). The findings suggest established evidence for relatively few agents, with preliminary and promising evidence for a larger group. Challenges and opportunities in the developing field of ASD psychopharmacology are identified, and recommendations for further research are provided.
ISSN
1573-3432
First Page
1592
Last Page
1605
Recommended Citation
Siegel, Matthew and Beaulieu, Amy A, "Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice." (2012). MaineHealth Maine Medical Center. 1302.
https://knowledgeconnection.mainehealth.org/mmc/1302